Monday, June 1, 2026

Social Media and Talc Claims Lead Mass Tort Filings on June 1

Federal courts saw 159 new mass tort filings on June 1, 2026, driven largely by a surge in litigation accusing tech giants of addicting minors and ongoing claims linking legacy cosmetics to cancer. The Social Media Adolescent Addiction Personal Injury Products Liability Litigation (MDL 3047) commanded the docket with 42 new cases asserting that platform algorithms are intentionally designed to foster youth dependency and cause severe mental health injuries. Wright & Schulte LLC anchored the day's volume (35), alongside new complaints from the Law Offices of Charles H Johnson and Verhine Verhine PLLC.

Legacy product liability remained a substantial driver of new caseloads, as the Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL 2738) added 29 actions alleging the company's asbestos-tainted baby powder caused ovarian cancer and mesothelioma. The Miller Firm LLC led that charge (15), with support from Ashcraft Gerel LLP (5). Close behind, Dicello Levitt LLP single-handedly advanced the Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation (MDL 3014) with a block of 21 new complaints asserting that sound-abatement foam in the sleep apnea machines degrades and forces toxic particles into patients' airways.

Further down the docket, the Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060) drew 10 suits from firms including Johnson Law Group and Douglas & London, centering on claims that endocrine-disrupting chemicals in cosmetic straighteners cause reproductive cancers. Meanwhile, the newly formed Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation (MDL 3140) picked up eight actions alleging the contraceptive injection causes brain tumors, brought by plaintiffs' counsel including Hochman Law Firm PLLC and Dovel & Luner. As steering committees continue to recruit across both legacy and emerging consumer health dockets, practitioners should watch whether these early summer spikes coalesce into broader coordinated filing strategies ahead of late-year bellwether selections.

Abbott Labs Faces New Lawsuit Over Shocks From Spinal Cord Stimulator

On June 2, 2026, a new product liability lawsuit was reported detailing severe injuries allegedly caused by Abbott Laboratories' Eterna spinal cord stimulator. The complaint alleges that the implanted pain-management device malfunctioned, delivering unprompted and painful electric shocks to the patient rather than therapeutic relief. The litigation underscores ongoing safety concerns regarding device programming, battery performance, and internal migration that have increasingly drawn regulatory and legal scrutiny. For medical device product liability practitioners, this development signals a growing focus on neurological implants as plaintiffs continue to assert failure-to-warn and design defect claims over unexpected shocks and worsened chronic pain. As more patients come forward with similar complication reports, the judicial system is expected to grapple with complex causation questions surrounding the neurostimulation technology.

Rhode Island Senate Reaches Deal to Revive Clergy Abuse Lawsuits

On June 2, 2026, the Rhode Island Senate reached a legislative deal to advance a clergy abuse lawsuit revival bill. The regulatory and legislative development is poised to open a new lookback window, temporarily lifting the statute of limitations to allow adult survivors of childhood sexual abuse to file civil claims against religious institutions that shielded perpetrators. By eliminating procedural barriers, this compromise fundamentally alters the liability landscape for the Catholic diocese and associated entities within the state. For plaintiffs' attorneys litigating systemic church abuse, the impending legislative enactment offers a critical avenue to pursue previously time-barred claims. The move aligns Rhode Island with the nationwide trend of expanding institutional accountability through legislative revival windows.